相关实验视频

扩散性肺部疾病与转移缺陷发生在腹腔疾病时

J Hood, A M Mason

Lancet (London, England)

|February 28, 1970

概括

No abstract available in PubMed .

相关概念视频

通过共同作者、期刊和引用图与本文相关的文章。

Taladegib for the treatment of idiopathic pulmonary fibrosis (ENV-IPF-101): a multicentre, randomised, double-blind, placebo-controlled, phase 2a trial.

The Lancet. Respiratory medicine·2025

Genetically predicted serum urate and cancer risk: a Mendelian randomization study.

Scandinavian journal of rheumatology·2025

Performance and enteric methane emissions from housed beef cattle fed silage produced on pastures with different forage profiles.

Animal : an international journal of animal bioscience·2023

Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment.

Osteoarthritis and cartilage·2019

A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee.

Osteoarthritis and cartilage·2017

A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study.

Osteoarthritis and cartilage·2017

查看所有相关文章